Skip to content

Hydralazine/Hydrochlorothiazide

    DEA Class; Rx

    Common Brand Names; Hydra-Zide

    • Thiazide Combos

    Hydralazine/hydrochlorothiazide is a fixed-combination tablet that combines a vasodilator, hydralazine and a thiazide diuretic, hydrochlorothiazide

    Hydralazine, a direct vasodilator, dilates arterioles with little effect on veins; decreases systemic resistance

    Hydrochlorothiazide, a thiazide diuretic, inhibits Na reabsorption in distal renal tubules resulting in increased excretion of Na+ and water, also K+ and H+ ions

    Indicated for the treatment of hypertension.

    Anuria

    Hypersensitivity to either component or sulfonamides

    Coronary artery disease

    Dissecting aortic aneurysm

    Mitral valve rheumatic heart disease

    Hydralazine (Common)

    • Palpitations
    • Hypotension
    • Tachycardia
    • Headache
    • Peripheral neuropathy
    • Anorexia
    • Diarrhea
    • Nausea/vomiting
    • Dyspnea
    • Nasal congestion
    • Agranulocytosis
    • Eosinophilia
    • Leukopenia
    • Hemolytic anemia
    • Thrombocytopenia

    Hydrochlorothiazide

    • AnorexiaEpigastric distress
    • Hypotension
    • Orthostatic hypotension
    • Photosensitivity
    • Anaphylaxis
    • Anemia
    • Confusion
    • Erythema multiforme
    • Stevens-Johnson syndrome
    • Exfoliative dermatitis including toxic epidermal necrolysis
    • Hypomagnesemia
    • Dizziness
    • Headache
    • Hyperuricemia

    This fixed-combination drug is not indicated for initial therapy of hypertension; requires therapy titrated to the individual patient before fixed-combination drug therapy initiated

    May induce SLE-type syndrome (usually at doses >200 mg/day); instruct patients to report joint/chest pain or fever; consider discontinuation if occurs

    DM, fluid or electrolyte imbalance, hyperuricemia or gout, liver disease, renal disease

    May aggravate digitalis toxicity

    Sensitivity reactions may occur with or without history of allergy or asthma

    CVA, severe renal impairment, volume depletion, preexisting hypotension, concurrency with other hypotensive agents

    Discontinue slowly to avoid rapid rise in BP

    Risk of male sexual dysfunction

    Acute transient myopia and acute angle-closure glaucoma has been reported, particularly with history of sulfonamide or penicillin allergy (hydrochlorothiazide is a sulfonamide)

    Pregnancy Category: C

    Lactation: enters breast milk; compatible

    Adults

    Hypertension

    Not for initial therapy

    Usual dose: 25 mg/25 mg PO q12hr

    Maximum: 100 mg/50 mg PO q12hr

    Dosage strength determined by individual titration

    Pediatric

    <18 years: Safety/efficacy not established

    Hydralazine/Hydrochlorothiazide

    capsule

    • 25mg/25mg
    • 50mg/50mg
    • 100mg/50mg